DrugRisk Announces NuvaRing Lawsuit Trials to Start in January

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

News Image
The resource center has added warnings from health experts linking contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills.

The birth control safety advocates at DrugRisk.com are announcing updated information for women using the contraceptive NuvaRing. As recent court records show the number of lawsuits alleging the device caused blood clots has increased, a federal judge has scheduled the first trial*.

DrugRisk is a free resource for patients taking popular prescription drugs. By providing the latest updates on product recalls, safety alerts, research and litigation news, they can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts linking contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

Due to the number of patients who have filed a NuvaRing lawsuit alleging blood clots, many cases are now consolidated in a special federal multidistrict litigation court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

The latest court records show the number of cases filed has grown over 4% in less than a month from 1,358 claims on August 15th to 1,419 as of September 11***.

Now, DrugRisk has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, has scheduled the first trial to start on January 27th*.

Lawyers are still helping those affected. Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. However, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*U.S. District Judge Rodney Sippel, 7/30/13; aboutlawsuits.com/wp-content/uploads/2013-07-30-NuvaRing-Order.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***JPML 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugRisk
888-415-1859
Email >
Visit website